Adaptive Biotechnologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. 

CEO
Chad Robins
CEOChad Robins
Employees
619
Employees619
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2009
Founded2009
Employees
619
Employees619

ADPT Key Statistics

Market cap
1.99B
Market cap1.99B
Price-Earnings ratio
-15.51
Price-Earnings ratio-15.51
Dividend yield
Dividend yield
Average volume
2.00M
Average volume2.00M
High today
$13.39
High today$13.39
Low today
$12.58
Low today$12.58
Open price
$12.68
Open price$12.68
Volume
1.25M
Volume1.25M
52 Week high
$13.39
52 Week high$13.39
52 Week low
$3.98
52 Week low$3.98

ADPT News

TipRanks 4d
Adaptive Biotechnologies down 5% after Genentech pact terminated

Shares of Adaptive Biotechnologies (ADPT) are down 60c, or 5%, to $12.44 after the company disclosed in a regulatory filing this morning that on August 13, the...

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own ADPT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.